Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Clinical Chemistry|December 20, 2003
High-throughput mutation detection method to scan BRCA1 and BRCA2 based on heteroduplex analysis by capillary array electrophoresisEva Esteban-Cardeñosa, Mercedes Duran, Mar Infante, et al.Human Mutation|March 26, 2003
Mutational analysis of BRCA2 in Spanish breast cancer patients from Castilla-Leon: identification of four novel truncating mutationsMercedes Duran, Eva Esteban-Cardeñosa, Eladio Velasco, et al.Journal of Human Genetics|June 8, 2006
High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain)Mar Infante, Mercedes Durán, Eva Esteban-Cardeñosa, et al.Clinical Biochemistry|July 21, 2009
Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriersInmaculada de Juan Jiménez, Eva Esteban Cardeñosa, Sarai Palanca Suela, et al.Electrophoresis|June 7, 2005
Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresisEladio Velasco, Mar Infante, Mercedes Durán, et al.Nature Protocols|April 3, 2007
Heteroduplex analysis by capillary array electrophoresis for rapid mutation detection in large multiexon genesEladio Velasco, Mar Infante, Mercedes Durán, et al.Medicina Clinica|October 19, 2002
[Molecular study of the BRCA1 and BRCA2 genes in 153 breast cancer families from Castilla and León (Spain): new nine unclassified variants identified]Eladio Velasco Sampedro, Eva Esteban Cardeñosa, Mar Infante Sanz, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 15, 2010
Advantage of high-resolution melting curve analysis over conformation-sensitive gel electrophoresis for mutational screening of BRCA1 and BRCA2 genesInmaculada de Juan Jiménez, Eva Esteban Cardeñosa, Sarai Palanca Suela, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patientsDavid J Sanz, Alberto Acedo, Mar Infante, et al.International Journal of Cancer|November 18, 2003
The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer populationAna Osorio, Raquel Rodríguez-López, Orland Díez, et al.Pageof 3